Risperidon Sandoz 2 mg Norwegia - norweski - Statens legemiddelverk

risperidon sandoz 2 mg

sandoz as - risperidon - tablett, filmdrasjert - 2 mg

Risperidon Sandoz 4 mg Norwegia - norweski - Statens legemiddelverk

risperidon sandoz 4 mg

sandoz as - risperidon - tablett, filmdrasjert - 4 mg

Sporanox 100 mg Norwegia - norweski - Statens legemiddelverk

sporanox 100 mg

janssen-cilag as - itrakonazol - kapsel, hard - 100 mg

Theo-Dur 200 mg Norwegia - norweski - Statens legemiddelverk

theo-dur 200 mg

karo pharma ab (1) - teofyllin - depottablett - 200 mg

Theo-Dur 300 mg Norwegia - norweski - Statens legemiddelverk

theo-dur 300 mg

karo pharma ab (1) - teofyllin - depottablett - 300 mg

Ozalin 2 mg/ ml Norwegia - norweski - Statens legemiddelverk

ozalin 2 mg/ ml

primex pharmaceuticals oy - midazolam - mikstur, oppløsning i endosebeholder - 2 mg/ ml

Tavlesse Unia Europejska - norweski - EMA (European Medicines Agency)

tavlesse

instituto grifols s.a. - fostamatinib disodium - trombocytopeni - andre systemiske hemostatics - tavlesse er indisert for behandling av kronisk immun trombocytopeni (itp) hos voksne pasienter som er refraktære til andre behandlinger.

Calquence Unia Europejska - norweski - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leukemi, lymfocytisk, kronisk, b-celle - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

Retsevmo Unia Europejska - norweski - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiske midler - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Midazolam Medical Valley 2.5 mg Norwegia - norweski - Statens legemiddelverk

midazolam medical valley 2.5 mg

medical valley invest ab - midazolamhydroklorid - munnvann, oppløsning - 2.5 mg